Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Sensors (Basel) ; 22(7)2022 Mar 24.
Artículo en Inglés | MEDLINE | ID: mdl-35408112

RESUMEN

In this work, a knee sleeve is presented for application in physical therapy applications relating to knee rehabilitation. The device is instrumented with sixteen piezoresistive sensors to measure knee angles during exercise, and can support at-home rehabilitation methods. The development of the device is presented. Testing was performed on eighteen subjects, and knee angles were predicted using a machine learning regressor. Subject-specific and device-specific models are analyzed and presented. Subject-specific models average root mean square errors of 7.6 and 1.8 degrees for flexion/extension and internal/external rotation, respectively. Device-specific models average root mean square errors of 12.6 and 3.5 degrees for flexion/extension and internal/external rotation, respectively. The device presented in this work proved to be a repeatable, reusable, low-cost device that can adequately model the knee's flexion/extension and internal/external rotation angles for rehabilitation purposes.


Asunto(s)
Nanocompuestos , Dispositivos Electrónicos Vestibles , Fenómenos Biomecánicos , Terapia por Ejercicio , Humanos , Articulación de la Rodilla , Rango del Movimiento Articular
2.
Hum Pathol ; 33(4): 405-9, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12055674

RESUMEN

PTEN is a tumor-suppressor gene with phosphatase activity that is mutated in a variety of cancers. We analyzed a series of 34 invasive and 18 in situ breast cancers with known molecular status of the PTEN genotype using immunohistochemistry. Reduced PTEN protein expression was seen in 38% of invasive cancers and in 11% of in situ cancers. The frequency of reduced expression was highest in stage II and III cancers. Reduced expression also correlated with aneuploidy. In addition, in tumors with both in situ and invasive components, expression within the ductal carcinoma in situ portion tended to reflect the expression pattern of the invasive component. These data suggest that PTEN expression is frequently reduced in advanced breast cancers.


Asunto(s)
Neoplasias de la Mama/genética , Monoéster Fosfórico Hidrolasas/genética , Proteínas Supresoras de Tumor/genética , Aneuploidia , Neoplasias de la Mama/química , Neoplasias de la Mama/patología , Carcinoma in Situ/química , Carcinoma in Situ/genética , Carcinoma in Situ/patología , Carcinoma Intraductal no Infiltrante/química , Carcinoma Intraductal no Infiltrante/genética , Carcinoma Intraductal no Infiltrante/patología , Genotipo , Humanos , Inmunohistoquímica , Pérdida de Heterocigocidad , Estadificación de Neoplasias , Fosfohidrolasa PTEN , Monoéster Fosfórico Hidrolasas/análisis , Proteínas Supresoras de Tumor/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA